BSEAGM/EGMResults26 Aug 2026
GKB Ophthalmics Ltd
The 44th Annual General Meeting of the Company was held on August 25, 2026 at 11:00 A.M. ,at the registered office of the Company at 16-A, Tivim Industrial Estate, Mapusa Goa-403526.
Pursuant ....
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026, where all resolutions were passed with requisite majority. The meeting was attended by 32 shareholders, including 4 promoters and 28 public shareholders. The resolutions included the adoption of standalone and consolidated financial statements, reappointment of Mr. Vikram Gupta, and other ordinary resolutions.
BSEAGM/EGMMgmt Change25 Aug 2026
GKB Ophthalmics Ltd
The 44th Annual General Meeting of the Company was held today i.e Tuesday , August 25th, 2026, at 11.00 A. M., at the Registered Office of the Company at 16- A, Tivim Industrial Estate, ....
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026, where the company's performance for the financial year 2025-26 was discussed. The meeting approved various resolutions, including the re-appointment of directors, related party transactions, and office or place of profit in a subsidiary company.
BSECompany UpdateResults14 Aug 2026
GKB Ophthalmics Ltd
Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, published in ....
GKB Ophthalmics Ltd has announced unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with total income from operations at ₹75.12 lakhs and net profit for the period at ₹45.69 lakhs.
BSEResultResults12 Aug 2026
GKB Ophthalmics Ltd
Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
The above unaudited Financial Results and the Limited Review Reports ....
GKB Ophthalmics Ltd has released its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, showing revenue from operations at Rs. 539.69 lakhs, other income at Rs. 47.35 lakhs, and total income at Rs. 687.71 lakhs. The company's expenses include cost of materials consumed, employee benefits expense, finance costs, depreciation and amortization expense, and other expenses. The profit before exceptional items is Rs. 173.94 lakhs, and the profit before tax is Rs. 73.91 lakhs. The company has also disclosed exceptional items of Rs. 149.4 lakhs.
BSEBoard MeetingResults12 Aug 2026
GKB Ophthalmics Ltd
The meeting of the Board of Directors of the Company was held on August 12, 2026 which considered and took on record inter alia the unaudited Standalone and Consolidated Financial Results ....
GKB Ophthalmics Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a write-off of AED 1,69,325.58 due to the closure of its subsidiary, Prime Ophthalmics Products PTY Limited. The company has also filed a writ petition against the recovery proceedings initiated by the Mamlatdar of Bardez Taluka.
BSECompany UpdateRegulatory1 Aug 2026
GKB Ophthalmics Ltd
Please find attached copies of newspaper cuttings of the Notice published in The Times of India (Goa Edition) dated August 01, 2026, Pudhari (Marathi) dated August 01, 2026, and Business ....
GKB Ophthalmics Ltd. has published a public notice in The Times of India (Goa Edition) and Pudhari (Marathi) regarding the completion of dispatch of notice of annual general meeting together with annual report for the financial year 2025-26. The notice also mentions the proposed Deed of Release/Relinquishment in favor of Mr. Abhishek Jaikumar Jain, relinquishing all rights, title, interest, and share in Flat Nos. 703 & 704, Building No. 5, Shanti Garden, Sector-3, Mira Road (East), Thane.
BSECompany Update31 Jul 2026
GKB Ophthalmics Ltd
Pursuant to Regulation 36(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company has sent a letter to those shareholders whose email addresses are ....
GKB Ophthalmics Ltd has sent a letter to shareholders whose email addresses are not registered with the company or its registrar, providing a web link to access the Annual Report for FY 2025-26. The company also reminds shareholders to update their KYC details and dematerialize physical securities.
BSECorp. Action31 Jul 2026
GKB Ophthalmics Ltd
Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act 2013, read with Rule 10 of Companies (Management ....
GKB Ophthalmics Ltd has announced a book closure from August 19 to August 25, 2026, for its 44th Annual General Meeting, with no dividend proposed for the year 2025-26.
BSEOthersResults31 Jul 2026
GKB Ophthalmics Ltd
Pursuant to Regulation 34 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the Annual Report along with the Notice of ....
GKB Ophthalmics Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of the 44th Annual General Meeting. The report is available on the company's website and has been sent electronically to members whose email addresses are registered with the company.
BSEBoard MeetingResults25 Jul 2026
GKB Ophthalmics Ltd
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
GKB Ophthalmics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve the Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.